Table 3.
Immunohistochemistry
| Case | Pan-CK | EMA | p63 | ASMA | S100 | GFAP | Calponin |
|---|---|---|---|---|---|---|---|
| MEC | |||||||
| 1 | − | + | − | f + | − | nd | + |
| 2 | + | nd | − | f + | f + | − | f + |
| 3 | f + | nd | − | f + | − | nd | f + |
| 4 | − | + | − | f + | − | − | nd |
| 5 | f + | − | nd | f+ | − | nd | nd |
| 6 | + | nd | + | + | − | nd | nd |
| 7 | + | + | − | − | f + | − | − |
| 8 | + | − | nd | nd | + | − | + |
| 9 | + | − | − | − | f+ | nd | − |
| 10 | + | + | + | nd | f+ | nd | nd |
| 8/10 | 4/7 | 2/8 | 6/8 | 5/10 | 0/4 | 4/6 | |
| 80 % | 57 % | 25 % | 75 % | 50 % | 0 % | 67 % | |
| EMC | |||||||
| 11 | − | − | + | f + | f + | f+ | nd |
| 12 | − | − | − | − | f + | − | nd |
| 13 | − | f+ | nd | − | − | − | nd |
| 14 | − | − | − | − | − | − | nd |
| 15 | − | f + | − | − | − | − | nd |
| 0/5 | 2/5 | 1/4 | 1/5 | 2/5 | 1/5 | ||
| 0 % | 40 % | 25 % | 20 % | 40 % | 20 % | ||
f focally, nd not done